ADVFN Logo ADVFN

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,671.14
1.01%
US Tech 100
19,186.00
1.08%
Dow Jones
41,883.25
0.73%
Brent Oil
70.515
0.51%
Bitcoin
84,688.59
2.39%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. AMEX
  6. Mallinckrodt plc (MNK)

  7. Mallinckrodt plc (MNK) News

MNK

Mallinckrodt (MNK)

Mallinckrodt plc
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:MNK
DateTimeSourceHeadlineSymbolCompany
11/14/20249:05AMPR Newswire (US)Mallinckrodt to Present at Jefferies London Healthcare ConferenceAMEX:MNKMallinckrodt plc
11/05/20246:45AMPR Newswire (US)Mallinckrodt plc Reports Third Quarter 2024 Financial Results and Raises Full Year GuidanceAMEX:MNKMallinckrodt plc
10/30/20246:50AMPR Newswire (US)Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection at the 2024 American Association for the Study of Liver Diseases (AASLD) Annual MeetingAMEX:MNKMallinckrodt plc
10/10/20246:52AMPR Newswire (US)Mallinckrodt Announces an Expanded Rollout of the INOmax® EVOLVE™ DS Delivery System in U.S. HospitalsAMEX:MNKMallinckrodt plc
09/17/20246:50AMPR Newswire (US)Mallinckrodt Announces Publication of Human Factors Studies and Arthritis Foundation Ease of Use® Certification of Acthar® Gel (repository corticotropin injection) Single-Dose Pre-filled SelfJect™ InjectorAMEX:MNKMallinckrodt plc
09/03/20243:45AMPR Newswire (US)THERAKOS™ CELLEX™ Photopheresis System Receives CE Certificate Under the European Union Medical Device Regulation (EU MDR)AMEX:MNKMallinckrodt plc
08/06/20246:45AMPR Newswire (US)Mallinckrodt plc Reports Second Quarter 2024 Financial Results and Raises Full Year GuidanceAMEX:MNKMallinckrodt plc
08/06/20246:35AMPR Newswire (US)Mallinckrodt Announces Availability of Acthar® Gel (repository corticotropin injection) Single-Dose Pre-filled SelfJect™ Injector in the U.S.AMEX:MNKMallinckrodt plc
08/05/20247:00AMPR Newswire (US)Mallinckrodt Reaches Agreement to Sell Therakos® Business to CVC for $925 MillionAMEX:MNKMallinckrodt plc
08/05/20247:00AMPR Newswire (US)Mallinckrodt Reaches Agreement to Sell Therakos® Business to CVC for $925 MillionAMEX:MNKMallinckrodt plc
08/01/20248:59AMPR Newswire (US)Mallinckrodt to Report Earnings Results for Second Quarter 2024AMEX:MNKMallinckrodt plc
08/29/20237:22AMIH Market NewsTuesday’s Wall Street Highlights: Alphabet, Verizon, Joann, Intel, Catalent, and moreAMEX:MNKMallinckrodt plc
08/28/20234:46AMPR Newswire (US)Mallinckrodt plc Takes Next Step to Implement Comprehensive Financial Restructuring Plan to Address Long-Term Debt and Opioid ObligationsAMEX:MNKMallinckrodt plc
08/28/202312:17AMPR Newswire (US)Mallinckrodt plc Takes Next Step to Implement Comprehensive Financial Restructuring Plan to Address Long-Term Debt and Opioid ObligationsAMEX:MNKMallinckrodt plc
08/23/20238:32AMPR Newswire (US)Mallinckrodt plc Enters into Restructuring Support Agreement with Key Stakeholders on the Terms of a Prepackaged Financial Restructuring PlanAMEX:MNKMallinckrodt plc
08/23/20238:22AMPR Newswire (US)Mallinckrodt plc Enters into Restructuring Support Agreement with Key Stakeholders on the Terms of a Prepackaged Financial Restructuring PlanAMEX:MNKMallinckrodt plc
08/09/20236:45AMPR Newswire (US)Mallinckrodt plc Reports Second Quarter 2023 Financial Results and Reaffirms Full Year GuidanceAMEX:MNKMallinckrodt plc
06/15/20236:52AMPR Newswire (US)Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection in Adult Patients with Hepatorenal Syndrome (HRS) at the European Association for the Study of the Liver (EASL) Congress 2023AMEX:MNKMallinckrodt plc
06/13/20232:30AMPR Newswire (US)Mallinckrodt Announces Publication of Real-World Data on the Use of Extracorporeal Photopheresis (ECP) in Heart Transplant PatientsAMEX:MNKMallinckrodt plc
06/01/20236:52AMPR Newswire (US)Mallinckrodt Presents Clinical Data for TERLIVAZ® (terlipressin) for Injection in Adults with Hepatorenal Syndrome (HRS) at the American Transplant Congress (ATC) 2023AMEX:MNKMallinckrodt plc
05/09/20236:45AMPR Newswire (US)Mallinckrodt plc Reports First Quarter 2023 Financial Results and Reaffirms Full Year GuidanceAMEX:MNKMallinckrodt plc
05/08/20236:52AMPR Newswire (US)Mallinckrodt Presents Clinical Data for TERLIVAZ® (terlipressin) for Injection in Adults with Hepatorenal Syndrome (HRS) at Digestive Disease Week (DDW) 2023AMEX:MNKMallinckrodt plc
05/05/20236:52AMPR Newswire (US)Mallinckrodt Recognized as Industry Innovator at National Organization for Rare Disorders (NORD) 2023 Rare Impact AwardsAMEX:MNKMallinckrodt plc
04/28/20238:00AMBusiness WireBuxton Helmsley Issues Letter to Mallinckrodt Plc. Regarding Failure to Address Evidential Multibillion-Dollar Asset Value Depreciation Expense Concealment SchemeAMEX:MNKMallinckrodt plc
04/24/20236:45AMPR Newswire (US)Mallinckrodt to Report Earnings Results for First Quarter 2023AMEX:MNKMallinckrodt plc
04/10/20236:53AMPR Newswire (US)Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection in Adult Patients with Hepatorenal Syndrome (HRS) at the National Kidney Foundation (NKF) 2023 Spring Clinical Meeting (SCM)AMEX:MNKMallinckrodt plc
03/21/20236:53AMPR Newswire (US)Mallinckrodt to Present New Retrospective Data on Effect of Acthar® Gel (Repository Corticotropin Injection) to Reduce Corticosteroid Use and Burden for Advanced Sarcoidosis at the Academy of Managed Care Pharmacy (AMCP) 2023 Annual MeetingAMEX:MNKMallinckrodt plc
03/09/20233:00AMPR Newswire (US)Mallinckrodt Announces Reimbursement Approval in Japan for the CELLEX® Extracorporeal Photopheresis (ECP) System for the Treatment of Chronic Graft Versus Host Disease (cGvHD)AMEX:MNKMallinckrodt plc
02/28/20236:45AMPR Newswire (US)Mallinckrodt plc Reports Fourth Quarter and Fiscal 2022 Financial Results and Provides 2023 GuidanceAMEX:MNKMallinckrodt plc
02/16/20238:03AMPR Newswire (US)Mallinckrodt to Present at Cowen's 43rd Annual Health Care ConferenceAMEX:MNKMallinckrodt plc
 Showing the most relevant articles for your search:AMEX:MNK

Your Recent History

USOTC
ZHUD
Zhuding (PK)
NASDAQ
PLUG
Plug Power
COIN
BTCUSD
Bitcoin
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
COIN
XRPUSD
Ripple
USOTC
HMBL
HUMBL (PK)
USOTC
NWBO
Northwest Biotherapeutics (QB)
NASDAQ
NVDA
NVIDIA
USOTC
CBRF
CyberFuels (PK)
USOTC
HIRU
Hiru (PK)
NASDAQ
AVXL
Anavex Life Sciences
USOTC
CYDY
CytoDyn (QB)
USOTC
RNVA
Rennova Health (CE)
USOTC
NLST
Netlist (QB)
USOTC
DBMM
Digital Brand Media and ... (PK)
USOTC
IFUS
Impact Fusion (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads